A case of primary hepatic mucosa-associated lymphoid tissue lymphoma incidentally found in the sustained virological response state of chronic hepatitis C: review of the literature of this rare disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Masood A, Kairouz S, Hudhud KH, Hegazi AZ, Banu A, Gupta NC (2009) Primary non-Hodgkin lymphoma of liver. Curr Oncol 16(4):74–77
Lazebnik LB, Vinnitskaia EV, Samokhvalova AV, Chikunova BZ, Efremov LI, Kniazev OV (2012) Primary non-Hodgkin lymphoma of the liver in patients with chronic virus. Eksp Klin Gastroenterol 6:107–114
Isaacson PG (2005) Update on MALT lymphomas. Best Pract Res Clin Haematol 18(1):57–68. https://doi.org/10.1016/j.beha.2004.08.003
Agmon-Levin N, Berger I, Shtalrid M, Schlanger H, Sthoeger ZM (2004) Primary hepatic lymphoma: a case report and review of the literature. Age Ageing 33(6):637–640. https://doi.org/10.1093/ageing/afh197
Yang XW, Tan WF, Yu WL, Shi S, Wang Y, Zhang YL, Zhang YJ, Wu MC (2010) Diagnosis and surgical treatment of primary hepatic lymphoma. World J Gastroenterol 16(47):6016–6019. https://doi.org/10.3748/wjg.v16.i47.6016
Dong S, Chen L, Chen Y, Chen X (2017) Primary hepatic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: a case report and literature review. Medicine (Baltimore) 96(13):e6305. https://doi.org/10.1097/MD.0000000000006305
Montaiban C (1995) Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 345:798–799
Ye MQ, Suriawinata A, Black C, Min AD, Strauchen J, Thung SN (2000) Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med 124(4):604–608. https://doi.org/10.1043/0003-9985(2000)124%3c0604:PHMZBC%3e2.0.CO;2
Mizuno S, Tabata M, Uemoto S, Imai H, Shiraki K (2002) Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C. J Hepatol 37:872–873
Bronowicki JP, Bineau C, Feugier P, Hermine O, Brousse N, Oberti F, Rousselet MC, Dharancy S, Gaulard P, Flejou JF, Cazals-Hatem D, Labouyrie E (2003) Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 37(4):781–787. https://doi.org/10.1053/jhep.2003.50121
Gockel HR, Heidemann J, Lugering A, Mesters RM, Parwaresch R, Domschke W, Lugering N (2005) Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma. Eur J Haematol 74(5):445–447. https://doi.org/10.1111/j.1600-0609.2005.00419.x
Orrego M, Guo L, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez-Luna H, Moss A, Reddy K, Rakela J, Vargas HE (2005) Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl 11(7):796–799. https://doi.org/10.1002/lt.20384
Nart D, Ertan Y, Yilmaz F, Yuce G, Zeytunlu M, Kilic M (2005) Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a liver transplant patient with hepatitis B cirrhosis. Transplant Proc 37(10):4408–4412. https://doi.org/10.1016/j.transproceed.2005.10.109
Doi H, Horiike N, Hiraoka A, Koizumi Y, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, Ninomiya T, Ishimaru Y, Miyagawa M, Takamura K, Kawasaki H, Kozuka T, Maeda T, Yoshino T (2008) Primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type: case report and review of the literature. Int J Hematol 88(4):418–423. https://doi.org/10.1007/s12185-008-0153-9
Merli M, Carli G, Arcaini L, Visco C (2016) Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. World J Gastroenterol 22(38):8447–8458. https://doi.org/10.3748/wjg.v22.i38.8447
Alric L, Besson C, Lapidus N, Jeannel J, Michot JM, Cacoub P, Canioni D, Pol S, Davi F, Rabiega P, Ysebaert L, Bonnet D, Hermine O (2016) Antiviral treatment of HCV-infected patients with B-cell non-Hodgkin lymphoma: ANRS HC-13 lympho-C study. PLoS ONE 11(10):e0162965. https://doi.org/10.1371/journal.pone.0162965
Peveling-Oberhag J, Arcaini L, Bankov K, Zeuzem S, Herrmann E (2016) The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis. J Viral Hepat 23(7):536–544. https://doi.org/10.1111/jvh.12518
El-Serag HB, Kanwal F, Richardson P, Kramer J (2016) Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology 64(1):130–137. https://doi.org/10.1002/hep.28535
Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB (2017) Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 153(4):996 e1001–1005 e1001. https://doi.org/10.1053/j.gastro.2017.06.012
Bao C, Wei J, Zhao X, Lin L, Chen D, Liu K, Qian W, Anas JM, Zhao K (2018) Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and review of the literature. Medicine (Baltimore) 97(10):e9877. https://doi.org/10.1097/MD.0000000000009877
Betianu CI, Dima A, Pavaloiu G (2017) Primary hepatic mucosa-associated lymphoid tissue lymphoma in a patient with no chronic liver disease: case report. Radiol Case Rep 12(4):715–719. https://doi.org/10.1016/j.radcr.2017.08.004
Bohlok A, De Grez T, Bouazza F, De Wind R, El-Khoury M, Repullo D, Donckier V (2018) Primary hepatic lymphoma mimicking a hepatocellular carcinoma in a cirrhotic patient: case report and systematic review of the literature. Case Rep Surg 2018:9183717. https://doi.org/10.1155/2018/9183717
Gherlan GS, Stoia R, Enyedi M, Dobrea C, Calistru PI (2016) Primary hepatic marginal zone lymphoma in a patient with chronic hepatitis C. MAEDICA J Clin Med 11(3):250–254
Obiorah IE, Johnson L, Ozdemirli M (2017) Primary mucosa-associated lymphoid tissue lymphoma of the liver: a report of two cases and review of the literature. World J Hepatol 9(3):155–160. https://doi.org/10.4254/wjh.v9.i3.155
Panda SS, Baisakh M, Panda A, Das H (2018) Primary hepatic marginal zone lymphoma: a rare coincidence. Curr Probl Cancer 42(3):322–328. https://doi.org/10.1016/j.currproblcancer.2018.01.002
Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, Ponzoni M, Pedrinis E, Dell'Oro S, Pruneri G, Filipazzi V, Dietrich PY, Gianni AM, Coiffier B, Cavalli F, Zucca E (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102(8):2741–2745. https://doi.org/10.1182/blood-2002-11-3496
Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A, Crosta C, Pedrinis E, Bertoni F, Calabrese L, Zucca E (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 23(9):1979–1983. https://doi.org/10.1200/JCO.2005.08.128
Nagata S, Harimoto N, Kajiyama K (2015) Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review. Surg Case Rep 1:87. https://doi.org/10.1186/s40792-015-0091-8
Hirokawa F, Kubo S, Nagano H, Nakai T, Kaibori M, Hayashi M, Takemura S, Wada H, Nakata Y, Matsui K, Ishizaki M, Uchiyama K (2015) Do patients with small solitary hepatocellular carcinomas without macroscopically vascular invasion require anatomic resection? Propensity score analysis. Surgery 157(1):27–36. https://doi.org/10.1016/j.surg.2014.06.080